Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

2,001 to 2,050 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • Efficacy and safety of saxagliptin in combination with metformin as initial therapy in Chinese patients with type 2 diabetes: Results from the START study, a multicentre, randomized, double-blind, active-controlled, phase 3 trial.

    Diabetes, obesity & metabolism2018PMID 28926170

  • Peri-operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trial.

    Diabetes, obesity & metabolism2018PMID 28940961

  • Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients.

    Microvascular research2018PMID 28954218

  • Metformin and β-cell function in insulin-treated patients with type 2 diabetes: A randomized placebo-controlled 4.3-year trial.

    Diabetes, obesity & metabolism2018PMID 28967181

  • Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.

    Journal of psychosomatic obstetrics and gynaecology2018PMID 28980870Indexed under metformin in PubMed's chemical list

  • Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis.

    Diabetic medicine2018PMID 29044702

  • Treatment satisfaction with ITCA 650, a novel drug-device delivering continuous exenatide, versus twice-daily injections of exenatide in type 2 diabetics using metformin.

    Diabetes, obesity & metabolism2018PMID 29053202

  • Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial.

    Gynecological endocrinology2018PMID 29076376

  • Metformin effect on TSH in subclinical hypothyroidism: randomized, double-blind, placebo-controlled clinical trial.

    Endocrine2018PMID 29080044

  • Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: A randomized study.

    The journal of obstetrics and gynaecology research2018PMID 29094444

  • Effect of Metformin on Plasma Fibrinogen Concentrations: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.

    Current pharmaceutical design2018PMID 29110599

  • Metformin for Rapidly Maturing Girls with Central Adiposity: Less Liver Fat and Slower Bone Maturation.

    Hormone research in paediatrics2018PMID 29131093

  • Short-term metformin and exercise training effects on strength, aerobic capacity, glycemic control, and mitochondrial function in children with burn injury.

    American journal of physiology2018PMID 29138224

  • Saxagliptin add-on therapy in Chinese patients with type 2 diabetes inadequately controlled by insulin with or without metformin: Results from the SUPER study, a randomized, double-blind, placebo-controlled trial.

    Diabetes, obesity & metabolism2018PMID 29144061

  • DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.

    Endocrine practice2018PMID 29144805Returned by a PubMed search for metformin

  • Fetal Growth and Birth Anthropometrics in Metformin-Exposed Offspring Born to Mothers With PCOS.

    The Journal of clinical endocrinology and metabolism2018PMID 29165598

  • Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.

    Diabetes & metabolic syndrome2018PMID 29221717

  • Comparative effectiveness of metformin monotherapy in extended release and immediate release formulations for the treatment of type 2 diabetes in treatment-naïve Chinese patients: Analysis of results from the CONSENT trial.

    Diabetes, obesity & metabolism2018PMID 29227571

  • Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

    Diabetes care2018PMID 29246950Indexed under metformin in PubMed's chemical list

  • Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.

    Diabetes, obesity & metabolism2018PMID 29266675

  • Is metformin poised for a second career as an antimicrobial?

    Diabetes/metabolism research and reviews2018PMID 29271563

  • All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes.

    Endocrine research2018PMID 29308936

  • Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.

    Diabetes, obesity & metabolism2018PMID 29316164

  • Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.

    BMC cancer2018PMID 29320995

  • Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.

    Clinical infectious diseases2018PMID 29325084

  • The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome.

    The Journal of clinical endocrinology and metabolism2018PMID 29325133

  • How safe is metformin when initiated in early pregnancy? A retrospective 5-year study of pregnant women with gestational diabetes mellitus from India.

    Diabetes research and clinical practice2018PMID 29325773

  • TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH).

    Diabetes care2018PMID 29326107

  • Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.

    PloS one2018PMID 29329345

  • The effects of metformin in type 1 diabetes mellitus.

    BMC endocrine disorders2018PMID 29338714

  • A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.

    PloS one2018PMID 29342199

  • Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials.

    Diabetes/metabolism research and reviews2018PMID 29351716

  • Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.

    Cardiovascular diabetology2018PMID 29368615

  • Efficacy and safety of sodium-glucose cotransporter 2 inhibitors as add-on to metformin and sulfonylurea treatment for the management of type 2 diabetes: a meta-analysis.

    Endocrine journal2018PMID 29375082

  • Two-year trial of intermittent insulin therapy vs metformin for the preservation of β-cell function after initial short-term intensive insulin induction in early type 2 diabetes.

    Diabetes, obesity & metabolism2018PMID 29377408

  • Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity.

    Clinical science (London, England2018PMID 29382697

  • Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan.

    PloS one2018PMID 29385156

  • In Vivo Evaluation of the Synergic Effect of Metformin and mTOR Inhibitors on the Endothelial Healing of Drug-eluting Stents in Diabetic Patients.

    Revista espanola de cardiologia (English ed.)2018PMID 29396233

  • Metformin does not affect postabsorptive hepatic free fatty acid uptake, oxidation or resecretion in humans: A 3-month placebo-controlled clinical trial in patients with type 2 diabetes and healthy controls.

    Diabetes, obesity & metabolism2018PMID 29405635

  • The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case-control study.

    BJOG2018PMID 29412502

  • Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.

    International journal of cancer2018PMID 29435974

  • A 52-week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add-on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone.

    Diabetes, obesity & metabolism2018PMID 29436761

  • Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: Post-hoc analysis of concomitant add-on versus sequential add-on to metformin and of triple versus dual therapy with metformin.

    Diabetes, obesity & metabolism2018PMID 29446523

  • The effect of Metformin treatment in obese insulin-resistant patients with euthyroid goiter.

    Acta clinica Belgica2018PMID 29452573

  • Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.

    Cancer epidemiology2018PMID 29453032

  • Pharmacokinetics of metformin in patients with gastrointestinal intolerance.

    Diabetes, obesity & metabolism2018PMID 29457876

  • Metformin Use and Severe Dengue in Diabetic Adults.

    Scientific reports2018PMID 29463812

  • Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.

    Medicine2018PMID 29465545

  • Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis.

    Diabetes & metabolism2018PMID 29477373Returned by a PubMed search for metformin

  • Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.

    BMC endocrine disorders2018PMID 29482528

The next 50 papers

← Previous 50